enVVeno Medical Corp Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- enVVeno Medical Corp stock issued during period, value, other for the quarter ending 2026-06-30 was $126.00K.
- enVVeno Medical Corp stock issued during period, value, other for the quarter ending 2024-09-30 was $13.59M.
- enVVeno Medical Corp stock issued during period, value, other for the quarter ending 2021-06-30 was $37.00K, a 98.12% decline year-over-year.
- enVVeno Medical Corp stock issued during period, value, other for the quarter ending 2021-03-31 was $38.13M.
- enVVeno Medical Corp stock issued during period, value, other for fiscal 2025 was $782.00K.
- enVVeno Medical Corp stock issued during period, value, other for fiscal 2021 was $960.00K, a 90.25% decline from fiscal 2020.
- enVVeno Medical Corp stock issued during period, value, other for fiscal 2020 was $9.85M, a 196.65% increase from fiscal 2019.
- enVVeno Medical Corp stock issued during period, value, other for fiscal 2019 was $3.32M.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2026-06-30 | $126.00K 10-Q · filed 2026-07-30 | |
| 2025-12-31 | $782.00K 10-K · filed 2026-03-26 | |
| 2024-09-30 | $13.59M 10-Q · filed 2025-10-30 | |
| 2021-12-31 | $960.00K 10-K · filed 2023-03-02 | |
| 2021-06-30 | $37.00K 10-Q · filed 2022-10-27 | |
| 2021-03-31 | $38.13M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $9.85M 10-K · filed 2021-03-31 | |
| 2020-09-30 | $3.88M 10-Q · filed 2020-11-17 | |
| 2020-06-30 | $1.97M 10-Q · filed 2020-11-17 | |
| 2019-12-31 | $3.32M 10-K · filed 2021-03-31 | |
| 2019-06-30 | $3.32M 10-Q · filed 2020-11-17 | |
| 2019-03-31 | $2.32M 10-Q · filed 2020-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |